Scientists at the Massachusetts Institute of Technology (MIT) have developed a groundbreaking approach to treating liver failure with the creation of injectable "satellite livers." These tiny engineered liver tissues, which combine liver cells (hepatocytes) with hydrogel microspheres, offer a potential solution to the global shortage of donor livers. Instead of undergoing a complex transplant surgery, patients could receive these miniature tissue grafts as an injectable treatment that assists